Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Recruiting 21Active not recruiting 20Suspended 5Completed 3Not yet recruiting 2Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Esophageal Squamous Cell Carcinoma 1Adenocarcinoma Of Esophagus 1

Interventions

Specimen Handling 22Magnetic Resonance Spectroscopy 20Carboplatin 17Gemcitabine 15pembrolizumab 13Cisplatin 13Paclitaxel 12Injections 11Interviews as Topic 10fludarabine 9Radiotherapy 9Cyclophosphamide 9Oxaliplatin 8Dexamethasone 8Biopsy 8Bevacizumab 8toripalimab 7Nivolumab 7Irinotecan 7Fluorouracil 7Bortezomib 7X-Rays 6Radiosurgery 6Pemetrexed 6Leucovorin 6Capecitabine 6durvalumab 5cemiplimab 5anlotinib 5Doxorubicin 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Taxes × 30 days × Clear all
NCT07618910 2026-06-01

Retlirafusp Alfa Plus Chemotherapy as Neoadjuvant Therapy for Thoracic ESCC

Tang-Du Hospital

Phase 2 Not yet recruiting
33 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT07594548 2026-05-18

Futibatinib With Paclitaxel and Ramucirumab for the Treatment of Locally Advanced or Unresectable Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma

Northwestern University

Phase 1 Not yet recruiting
18 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus

Data powered by HemOnc (CC BY 4.0) Colophon âš¡